Select Publications
Book Chapters
2017, 'Influence of Purity and Surface Oxidation on Cytotoxicity of Multiwalled Carbon Nanotubes with Human Neuroblastoma Cells', in Nanomedicine in Cancer, Pan Stanford, pp. 297 - 316, http://dx.doi.org/10.1201/b22358-11
,, 2017, 'Chapter 10: Curcumin‒Loaded γ ‒Cyclodextrin Liposomal Nanoparticles as Delivery Vehicles for Osteosarcoma', in Dhule SS; Penfornis P; Frazier T; Walker R; Feldman J; Tan G; He J; Alb A; John V; Pochampally R (ed.), Nanomedicine in Cancer, CRC Press, pp. 265 - 296, http://dx.doi.org/10.1201/9781315114361-11
2017, 'Influence of Purity and Surface Oxidation on Cytotoxicity of Multiwalled Carbon Nanotubes with Human Neuroblastoma Cells', in Balogh LP (ed.), Nanomedicine in Cancer, PAN STANFORD PUBLISHING PTE LTD, pp. 297 - 316
,2017, 'Physiological and clinical considerations of drug delivery systems containing carbon nanotubes and graphene', in Drug Delivery Approaches and Nanosystems: Volume 2: Drug Targeting Aspects of Nanotechnology, pp. 205 - 224, http://dx.doi.org/10.1201/9781315225364
,2013, 'Polyphenol Conjugate: Synthesis and Potential Biomedical Applications', in Recent Advances in Drug Delivery Research, Nova Science Publishers, USA
,2012, 'Manipulation, Guidance and Tracking of Mesenchymal Stem Cells for Regenerative Medicine and Transplantation: The Role of Magnetic Nanoparticles', in Stem Cells and Cancer Stem Cells, Volume 7 Therapeutic Applications in Disease and Injury, Springer Science & Business Media
,2011, 'Imaging and Biomedical Application of Magnetic Carbon Nanotubes', in Naraghi M (ed.), CARBON NANOTUBES - GROWTH AND APPLICATIONS, INTECH EUROPE, pp. 189 - 210, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000371131400009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'Physical properties of carbon nanotubes for therapeutic applications', in Klingeler R; Sim RB (ed.), Carbon Nanostructures, pp. 3 - 26, http://dx.doi.org/10.1007/978-3-642-14802-6_1
,Journal articles
2024, 'A novel network-based method identifies a cuproplasia-related pan-cancer gene signature to predict patient outcome', Human Genetics, 143, pp. 1145 - 1162, http://dx.doi.org/10.1007/s00439-024-02673-2
,2024, 'Near-Infrared Ratiometric Fluorescent Probe for Detecting Endogenous Cu2+ in the Brain', ACS Sensors, 9, pp. 2858 - 2868, http://dx.doi.org/10.1021/acssensors.3c02549
,2024, 'DIPG-35. OVERCOMING THE BLOOD-BRAIN BARRIER CHALLENGE IN DIFFUSE MIDLINE GLIOMA', Neuro-Oncology, 26, http://dx.doi.org/10.1093/neuonc/noae064.088
,2024, 'DIPG-76. PEDIATRIC PATIENTS WITH DIFFUSE MIDLINE GLIOMA DEMONSTRATE AN UNEXPECTED PREVALENCE OF GERMLINE VARIANTS IN HOMOLOGOUS RECOMBINATION GENES', Neuro-Oncology, 26, http://dx.doi.org/10.1093/neuonc/noae064.129
,2024, 'Dual-responsive chondroitin sulfate self-assembling nanoparticles for combination therapy in metastatic cancer cells', International Journal of Pharmaceutics: X, 7, http://dx.doi.org/10.1016/j.ijpx.2024.100235
,2024, 'Biocompatible cellulose nanocrystal-based Trojan horse enables targeted delivery of nano-Au radiosensitizers to triple negative breast cancer cells', Nanoscale Horizons, 9, pp. 1211 - 1218, http://dx.doi.org/10.1039/d4nh00042k
,2024, 'Abstract 1418: Priming of the glioblastoma tumour microenvironment via copper chelation to enhance the efficacy of immunotherapies', Cancer Research, 84, pp. 1418 - 1418, http://dx.doi.org/10.1158/1538-7445.am2024-1418
,2024, 'Abstract 2673: Copper chelation overcomes the immunosuppressive neuroblastoma microenvironment to potentiate anti-GD2 antibody therapy', Cancer Research, 84, pp. 2673 - 2673, http://dx.doi.org/10.1158/1538-7445.am2024-2673
,2024, 'Abstract 3056: Copper chelation modulates YTHDF2 RNA-binding protein localization and global translation, in neuronal cancers', Cancer Research, 84, pp. 3056 - 3056, http://dx.doi.org/10.1158/1538-7445.am2024-3056
,2024, 'Abstract 3636: Myeloid cell rebound associated with GD2-CAR-T cell therapy in solid tumor patients', Cancer Research, 84, pp. 3636 - 3636, http://dx.doi.org/10.1158/1538-7445.am2024-3636
,2024, 'Abstract 4942: Unraveling a prognostic and predictive 8-gene signature related to cuproplasia in pan-cancer', Cancer Research, 84, pp. 4942 - 4942, http://dx.doi.org/10.1158/1538-7445.am2024-4942
,2024, 'Abstract 525: A comprehensive approach: Copper chelation therapy modulates epigenetic, kinase signaling and metabolic pathways in diffuse midline gliomas (DMG)', Cancer Research, 84, pp. 525 - 525, http://dx.doi.org/10.1158/1538-7445.am2024-525
,2024, 'In Vivo Behavior of Systemically Administered Encapsulin Protein Nanocages and Implications for their use in Targeted Drug Delivery', Advanced Therapeutics, 7, http://dx.doi.org/10.1002/adtp.202300360
,2024, 'A road map for the treatment of pediatric diffuse midline glioma', Cancer Cell, 42, pp. 1 - 5, http://dx.doi.org/10.1016/j.ccell.2023.11.002
,2024, 'In Vivo Behavior of Systemically Administered Encapsulin Protein Nanocages and Implications for their use in Targeted Drug Delivery (Adv. Therap. 2/2024)', Advanced Therapeutics, 7, http://dx.doi.org/10.1002/adtp.202470003
,2023, 'A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer', Genome Medicine, 15, http://dx.doi.org/10.1186/s13073-023-01170-x
,2023, 'Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer', Cell and Bioscience, 13, http://dx.doi.org/10.1186/s13578-023-01083-7
,2023, 'Evolving approaches in glioma treatment: harnessing the potential of copper metabolism modulation', RSC Advances, 13, pp. 34045 - 34056, http://dx.doi.org/10.1039/d3ra06434d
,2023, 'Evaluating the Efficiency of Chitosan-Graphene Oxide Hybrid Hydrogels as Drug Delivery Systems', Macromolecular Materials and Engineering, 308, http://dx.doi.org/10.1002/mame.202300166
,2023, 'Endogenous PP2A inhibitor CIP2A degradation by chaperone-mediated autophagy contributes to the antitumor effect of mitochondrial complex I inhibition', Cell Reports, 42, http://dx.doi.org/10.1016/j.celrep.2023.112616
,2023, 'Tuning the Anthranilamide Peptidomimetic Design to Selectively Target Planktonic Bacteria and Biofilm', Antibiotics, 12, pp. 585, http://dx.doi.org/10.3390/antibiotics12030585
,2023, 'Q1291H-CFTR molecular dynamics simulations and ex vivo theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patient', Frontiers in Molecular Biosciences, 10, http://dx.doi.org/10.3389/fmolb.2023.1148501
,2022, 'GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma', Journal for ImmunoTherapy of Cancer, 10, http://dx.doi.org/10.1136/jitc-2022-005187
,2022, 'Hyaluronic Acid within Self-Assembling Nanoparticles: Endless Possibilities for Targeted Cancer Therapy', Nanomaterials, 12, http://dx.doi.org/10.3390/nano12162851
,2022, 'Curcumin and Graphene Oxide Incorporated into Alginate Hydrogels as Versatile Devices for the Local Treatment of Squamous Cell Carcinoma', Materials, 15, pp. 1648, http://dx.doi.org/10.3390/ma15051648
,2021, 'Tp53 mutation is a prognostic factor in lower grade glioma and may influence chemotherapy efficacy', Cancers, 13, pp. 5362, http://dx.doi.org/10.3390/cancers13215362
,2021, 'Copper: An Intracellular Achilles’ Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics', ChemMedChem, 16, pp. 2315 - 2329, http://dx.doi.org/10.1002/cmdc.202100172
,2021, 'Dextran‐curcumin nanosystems inhibit cell growth and migration regulating the epithelial to mesenchymal transition in prostate cancer cells', International Journal of Molecular Sciences, 22, http://dx.doi.org/10.3390/ijms22137013
,2021, 'Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG', Cell Reports, 35, pp. 108994, http://dx.doi.org/10.1016/j.celrep.2021.108994
,2021, 'Alginate bioconjugate and graphene oxide in multifunctional hydrogels for versatile biomedical applications', Molecules, 26, pp. 1355, http://dx.doi.org/10.3390/molecules26051355
,2021, 'Doxorubicin-loaded gold nanoarchitectures as a therapeutic strategy against diffuse intrinsic pontine glioma', Cancers, 13, pp. 1 - 20, http://dx.doi.org/10.3390/cancers13061278
,2021, 'Carbon Nanohorns as Effective Nanotherapeutics in Cancer Therapy', C-JOURNAL OF CARBON RESEARCH, 7, http://dx.doi.org/10.3390/c7010003
,2021, 'Ageing impairs the airway epithelium defence response to SARS-CoV-2', , http://dx.doi.org/10.1101/2021.04.05.437453
,2020, 'DIPG-83. USING COPPER CHELATING AGENTS TO TARGET RECEPTOR TYROSINE KINASE SIGNALLING IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)', Neuro-Oncology, 22, pp. iii303 - iii303, http://dx.doi.org/10.1093/neuonc/noaa222.124
,2020, 'Natural polysaccharide carriers in brain delivery: Challenge and perspective', Pharmaceutics, 12, http://dx.doi.org/10.3390/pharmaceutics12121183
,2020, 'Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion', Cancer Research, 80, pp. 4129 - 4144, http://dx.doi.org/10.1158/0008-5472.CAN-20-0471
,2020, 'Functionalized carbon nanostructures versus drug resistance: Promising scenarios in cancer treatment', Molecules, 25, http://dx.doi.org/10.3390/molecules25092102
,2020, 'Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation', Theranostics, 10, pp. 6411 - 6429, http://dx.doi.org/10.7150/thno.42602
,2020, 'Dextran-curcumin nanoparticles as a methotrexate delivery vehicle: A step forward in breast cancer combination therapy', Pharmaceuticals, 13, pp. 2, http://dx.doi.org/10.3390/ph13010002
,2019, 'Poor dietary polyphenol intake in childhood cancer patients', Nutrients, 11, http://dx.doi.org/10.3390/nu11112835
,2019, 'Combining carbon nanotubes and chitosan for the vectorization of methotrexate to lung cancer cells', Materials, 12, http://dx.doi.org/10.3390/ma12182889
,2019, 'Magnetic graphene oxide nanocarrier for targeted delivery of cisplatin: A perspective for glioblastoma treatment', Pharmaceuticals, 12, http://dx.doi.org/10.3390/ph12020076
,